Enhanced Coordinated Specialty Care for Early Psychosis
Cluster Randomized Trial of Enhanced Coordinated Specialty Care (CSC 2.0) for Early Psychosis
2 other identifiers
interventional
350
1 country
5
Brief Summary
The goal of this clinical trial is to compare engagement in treatment in coordinated specialty care (CSC) to five extra care elements (CSC 2.0) in first-episode psychosis. The main question it aims to answer is:
- Does the addition of certain elements of care increase the number of visits in treatment for first-episode psychosis? Participants will either:
- Receive care as usual (CSC) or
- Receive care as usual (CSC) plus five additional care elements (CSC 2.0):
- Individual peer support
- Digital outreach
- Care coordination
- Multi-family group therapy
- Cognitive remediation
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2024
Longer than P75 for not_applicable
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 26, 2023
CompletedFirst Posted
Study publicly available on registry
October 10, 2023
CompletedStudy Start
First participant enrolled
February 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2028
February 27, 2026
February 1, 2026
4.7 years
September 26, 2023
February 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Months Engaged in Care
Number of months each participant had ≥4 visits in a 12-month period
12 months following clinic intake
Secondary Outcomes (4)
Clinic Visit Number
12 months following clinic intake
Clinic Visit Type
12 months following clinic intake
Duration of Treatment
Up to 12 months - measured as time between clinic intake and detachment
Proportion in Arm Still in Clinic
12 months following clinic intake
Other Outcomes (3)
Exploratory Analysis of symptom and functioning measures in EPINET Core Assessment Battery (CAB)
12 months following clinic intake
Proportion of Early Detachment
1 month
Months Engaged in Care - extension of primary outcome
24 months
Study Arms (2)
Coordinated Specialty Care (CSC; standard of care)
NO INTERVENTIONCare as usual; no intervention.
Enhanced Coordinated Speciality Care (CSC 2.0)
EXPERIMENTALCSC 2.0 arm will be offered 1:1 peer support, digital outreach, care coordination, multi-family group therapy, and cognitive remediation (if applicable).
Interventions
* The study staff clinician will review all medical issues for each patient and reach out to primary care providers (PCP), dieticians, and other medical providers as needed. * The study staff clinician will serve as point person for communication with emergency departments and inpatient providers if the patient requires those levels of care. * The clinician will communicate with outside providers to provide background and ensure health decision making by those providers, visit and support patients as appropriate, access outside records and share with rest of the care team, and most critically ensure that a proper discharge plan has been made for the patient including care appointments, access to prescriptions and any new referrals made during hospitalization.
• Patients will be offered weekly 1:1 sessions with a Peer Provider as part of routine care in a mixture of in-person and virtual formats as appropriate to support patients around treatment decisions, and recovery.
• mindLAMP smartphone application for various kinds of outreach including but not limited to medication and/or appointment reminders, resources, and activities such as breathing and meditation exercises.
* For participants identified as needing and/or wanting support around cognition. * The cognitive remediation program is available online or in-app and offers memory, attention, processing speed, executive functioning, and social cognition training activities.
* Families whose loved ones are in CSC clinic will be offered weekly group sessions with a study staff clinician. * Each group may include 5-8 families and include a mixture of in-person and virtual formats. * These groups will be open-ended, including psychoeducation, and practical problem-solving discussions around care and other topics.
Eligibility Criteria
You may qualify if:
- People undergoing an intake evaluation to CSC for first-episode psychosis in one of the following outpatient clinics:
- McLean Hospital OnTrack (OnTrack Clinic)
- Massachusetts General Hospital (FEPP Clinic)
- Boston Medical Center (WRAP Clinic)
- Cambridge Health Alliance (RISE Clinic)
- UMass Memorial Health Care (STEP Clinic)
- ServiceNet (PREP West)
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mclean Hospitallead
- Boston Medical Centercollaborator
- Cambridge Health Alliancecollaborator
- University of Massachusetts, Worcestercollaborator
- National Institute of Mental Health (NIMH)collaborator
- Massachusetts General Hospitalcollaborator
Study Sites (5)
McLean Hospital OnTrack Clinic
Belmont, Massachusetts, 02478, United States
Massachusetts General Hospital FEPP Clinic
Boston, Massachusetts, 02114, United States
Boston Medical Center WRAP
Boston, Massachusetts, 02118, United States
Cambridge Health Alliance RISE Clinic
Cambridge, Massachusetts, 02139, United States
UMass Memorial Community Healthlink STEP Clinic
Worcester, Massachusetts, 01610, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dost Ongur, MD, PhD
Mclean Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, LEAP Center
Study Record Dates
First Submitted
September 26, 2023
First Posted
October 10, 2023
Study Start
February 1, 2024
Primary Completion (Estimated)
October 1, 2028
Study Completion (Estimated)
October 1, 2028
Last Updated
February 27, 2026
Record last verified: 2026-02